Company Filing History:
Years Active: 2011-2020
Title: The Innovations of Darryl Wayne Hilliard
Introduction
Darryl Wayne Hilliard is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. With a total of 2 patents to his name, Hilliard's work has the potential to impact the treatment of various neurological disorders.
Latest Patents
Hilliard's latest patents include innovative compounds that serve as positive allosteric modulators. The first patent focuses on dopamine D1 receptor positive allosteric modulators, which are designed to treat symptoms of Parkinson's disease, schizophrenia, ADHD, and Alzheimer's disease. The compounds, characterized by a specific chemical formula, offer new avenues for therapeutic intervention. The second patent involves thienopyridines as allosteric potentiators of the M4 muscarinic receptor, aimed at addressing disorders associated with muscarinic receptors.
Career Highlights
Darryl Wayne Hilliard is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in drug development. His work at Eli Lilly has allowed him to focus on groundbreaking research that seeks to improve the lives of patients suffering from complex neurological conditions.
Collaborations
Hilliard has collaborated with esteemed colleagues, including Almudena Rubio Esteban and Junliang Hao. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to more effective therapeutic solutions.
Conclusion
Darryl Wayne Hilliard's contributions to the field of pharmaceuticals through his innovative patents highlight his dedication to advancing medical science. His work has the potential to significantly improve treatment options for patients with neurological disorders.